Quarterly report [Sections 13 or 15(d)]

Consolidated Statements of Cash Flows (Unaudited)

v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:            
Loss from continuing operations $ (2,374,653)   $ (421,604) $ (3,607,800) $ (1,814,999)  
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:            
Depreciation and amortization       121,055 163,209  
Noncash lease expense       68,542 68,541  
Stock-based compensation expense       40,115 138,038  
Provision for doubtful accounts       94,597 4,431 $ 13,986
Unrealized loss on investment       44,000 0  
Loss on disposal of property, plant and equipment       1,329  
Changes in operating assets and liabilities, net of effects of discontinued operations:            
Accounts receivable       102,835 149,569  
Prepaid expenses and other current assets       (233,452) 78,930  
Accounts payable       380,960 130,863  
Accrued expenses       142,230 (3,142)  
Other current liabilities       12,246  
Lease liability       (80,883) (79,045)  
Deferred revenue       (580,108) (162,198)  
Net cash used in operating activities       (3,495,663) (1,324,474)  
Cash flows from investing activities:            
Payments for technology developed       0 (201,620)  
Purchases of property and equipment       (3,996) 0  
Payments to acquire investments       (1,300,000) 0  
Purchases of intangible assets       (2,900,000) 0  
Net cash used in investing activities       (4,203,996) (201,620)  
Cash flows from financing activities:            
Proceeds from the sale of common stock       5,414,246 949,990  
Proceeds from (Repayment of) short-term debt       819,516 0  
Proceeds from Noncontrolling Interests       0 82,140  
Net cash provided by (used in) financing activities       6,233,762 1,032,130  
Net decrease in cash and cash equivalents       (1,465,897) (493,964)  
Cash, cash equivalents, beginning of period   $ 133,677   1,731,155 627,641 627,641
Cash and cash equivalents, end of period $ 265,258 $ 1,731,155 $ 133,677 265,258 133,677 $ 1,731,155
Supplemental disclosures of other cash flow information:            
Cash paid for income taxes       0 0  
Non-cash amortization of commitment funding       187,500 281,250  
Copyrights [Member]            
Supplemental disclosures of other cash flow information:            
Non-cash stock issuance       1,800,000 0  
Remote More [Member]            
Supplemental disclosures of other cash flow information:            
Non-cash stock issuance       $ 300,000 $ 0